
Generic-Drug Stocks Get Healthier
Despite increased judicial and regulatory scrutiny making their longer-term prospects somewhat uncertain, makers of generic pharmaceuticals have recently been treating their shareholders well.
Despite increased judicial and regulatory scrutiny making their longer-term prospects somewhat uncertain, makers of generic pharmaceuticals have recently been treating their shareholders well.